Search Results - "Antonuzzo A"

Embedding nutrition into routine oncology care: about time?

Authors: Laird, Barry J. A. Antonuzzo, Lorenzo Cabrero, Darío Sánchez et al.

Source: Oncology Reviews. 2026, p1-9. 9p.

Prognostic role of hERG1 Potassium Channels in Neuroendocrine Tumours of the Ileum and Pancreas.

Authors: Iorio, Jessica Antonuzzo, Lorenzo Scarpi, Emanuela et al.

Source: International Journal of Molecular Sciences. Sep2022, Vol. 23 Issue 18, pN.PAG-N.PAG. 18p.

Agnostic phase II, multicenter, single-arm study with DURVAlumab plus carboplatin or cisplatin and etoposide as first-line treatment in extensive stage - Extrapulmonary Small Cell Carcinoma (EPSCC) patients – DURVASCC trial (GOIRC-01-2021).

Authors: Damato, Angela Maglietta, Giuseppe Antonuzzo, Lorenzo et al.

Source: BMC Cancer. 11/12/2025, Vol. 25 Issue 1, p1-9. 9p.

This result is not displayed to guests.
Login for full access.

Re: Ruben Raychaudhuri, Ali Raza Khaki, Mary W. Redman, et al. Neoadjuvant Pembrolizumab and Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Nonurothelial Histologic Subtypes of Muscle-invasive Bladder Cancer: A Phase 2 Trial. Eur Urol. 2025;88:559–563

Authors: Roviello, Giandomenico Antonuzzo, Lorenzo

Source: European Urology. Mar2026, Vol. 89 Issue 3, pe73-e73. 1p.

Supportive therapies in the prevention of chemotherapy-induced febrile neutropenia and appropriate use of granulocyte colony-stimulating factors: a Delphi consensus statement.

Authors: Adamo, Vincenzo Antonuzzo, Lorenzo Danova, Marco et al.

Source: Supportive Care in Cancer. Dec2022, Vol. 30 Issue 12, p9877-9888. 12p.

This result is not displayed to guests.
Login for full access.

Cytokinetic-driven myeloprotection after cytotoxic chemotherapy: from an old idea to a new clinical approach.

Authors: Sbrana, Andrea Antonuzzo, Andrea Danova, Marco

Source: Supportive Care in Cancer. Sep2022, Vol. 30 Issue 9, p7057-7060. 4p.

Pharmacological interactions between psychotropic drugs and anticancer treatments: implications for clinical practice.

Authors: Caruso, Valerio Pacciardi, Bruno Antonuzzo, Andrea et al.

Source: Supportive Care in Cancer. Feb2026, Vol. 34 Issue 2, p1-16. 16p.

Peripherally or centrally inserted central catheters: what is the best vascular access device for cancer patients?

Authors: Gonella, Silvia Antonuzzo, Andrea Bossi, Paolo

Source: Supportive Care in Cancer. Jun2021, Vol. 29 Issue 6, p2803-2806. 4p.

This result is not displayed to guests.
Login for full access.

Comment on "Dexamethasone-sparing on days 2–4 with combined palonosteron, neurokinin-1 receptor antagonist, and olanzapine in cisplatin: a randomized phase III trial (SPARED Trial)".

Authors: Celio, Luigi Antonuzzo, Andrea Aapro, Matti S.

Source: British Journal of Cancer. Apr2024, Vol. 130 Issue 6, p895-896. 2p.

Oxaliplatin-Based Chemotherapy in Advanced Neuroendocrine Tumors: Clinical Outcomes and Preliminary Correlation with Biological Factors.

Authors: Spada, Francesca antonuzzo, Lorenzo Marconcini, Riccardo et al.

Source: Neuroendocrinology. Sep2016, Vol. 103 Issue 6, p806-814. 9p. 5 Charts, 1 Graph.

Diarrhoea in adult cancer patients: ESMO Clinical Practice Guidelines.

Authors: Bossi, P Antonuzzo, A Cherny, N I et al.

Source: Annals of Oncology. 2018 Supplement, Vol. 29, piv126-iv142. 17p. 2 Diagrams, 11 Charts.

Corrigendum to "The emerging HER2 landscape in Colorectal Cancer: The key to unveil the future treatment algorithm?" [Crit. Rev. Oncol./Hematol. 204 (2024) 104515].

Authors: Antonuzzo, Lorenzo¹ (AUTHOR) lorenzo.antonuzzo@unifi.it

Source: Critical Reviews in Oncology/Hematology. Dec2024, Vol. 204, pN.PAG-N.PAG. 1p.

KRAS and NRAS mutation detection in circulating DNA from patients with metastatic colorectal cancer using BEAMing assay: Concordance with standard biopsy and clinical evaluation.

Authors: Lastraioli, Elena Antonuzzo, Lorenzo Fantechi, Beatrice et al.

Source: Oncology Letters. Jan2021, Vol. 21 Issue 1, pN.PAG-N.PAG. 1p.

Optimizing First-Line Chemotherapy in Metastatic Pancreatic Cancer: Efficacy of FOLFIRINOX versus Nab-Paclitaxel Plus Gemcitabine.

Authors: Di Costanzo, Francesco Di Costanzo, Federica Antonuzzo, Lorenzo et al.

Source: Cancers. Jan2023, Vol. 15 Issue 2, p416. 11p.

Impact of a supportive care service for cancer outpatients: management and reduction of hospitalizations. Preliminary results of an integrated model of care.

Authors: Antonuzzo, A. Vasile, E. Sbrana, A. et al.

Source: Supportive Care in Cancer. Jan2017, Vol. 25 Issue 1, p209-212. 4p.

Re: ctDNA-guided Adjuvant Atezolizumab in Muscle-invasive Bladder Cancer.

Authors: Roviello, Giandomenico Vascotto, Ismaela Anna Antonuzzo, Lorenzo

Source: European Urology. May2026, Vol. 89 Issue 5, p475-476. 2p.

Re: Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer.

Authors: Roviello, Giandomenico Mancini, Silvia Antonuzzo, Lorenzo

Source: European Urology. May2026, Vol. 89 Issue 5, p476-477. 2p.